3883 news items
Page 6 of 100
svxvag6p
KEYS
20 May 24
detailed in Keysight's filings with the Securities and Exchange Commission on Keysight's yearly report on Form 10-K for the period ended October 31
feyq3383m6rg8mi7lf1ubobkv
REGN
20 May 24
. INDICATIONS DUPIXENT is a prescription medicine used: to treat adults and children 6 months of age
p1ul3y v6eazbw4amjqzcck8ttshdq2qvnclbyx
REGN
20 May 24
@sanofi.comVictor Rouault | + 33 6 70 93 71 40
e8mk3u9a7k12uibl buyb3zu2sm5
20 May 24
has helped more than 9,200 adults graduate through similar programs in nine other states. The results of a survey taken 6-9 months after graduation
nrk7346j4wmzxlhgpzewem47 ohx0rq2wy9cpwdc1i6iz6mcaelxsva10g
20 May 24
vertically integrated STEM curricula throughout K-12. Establish stackable STEM credentials, leading to industry-recognized CTE certificates and STEM
j2iaoyg5m6byc1rem9r7bm9hwv7nodtvaackw3c4914l6pdyxp 2bwb7
OLB
20 May 24
, announced today that it has received a written letter from Nasdaq, which has determined that for the last 10 consecutive business days, from May 6, 2024
pidvpy6v39kut8ykwtzzcr0lfx4c8082
HIMS
20 May 24
in the "Risk Factors" section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any
635sjzd96 pwy6zv2pnh8cv9spdjc0ix3gvwycawzu6simzr6
NCLH
20 May 24
recently filed Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. The above examples are not exhaustive
xq4a7k rcv
GRI
20 May 24
products, and any related restrictions and limitations of any cleared or approved product; (6) the inability of the Company to identify, in-license
rdc f2who1
OI
20 May 24
consolidation of the Company's customer base, (6) the Company's ability to improve its glass melting technology, known as the modular advanced glass
zilnpaxmkrs5qfabj3fpn0k4fvhpkypjkfvmjll7lt
JCI
20 May 24
to be June 6, 2024, the third business day after the Early Tender Date. Securities validly tendered at or prior to the Early Tender Date
wdhhhc6p4clc797qghex001ptlopxm65otywvs2tnamhpe
STRR
20 May 24
report on Form 8-K filed with the Securities and Exchange Commission on May 20, 2024. About Star Equity Holdings, Inc
eggu3h 5yweyswva55320gyaye78uq78hqju6initwisq06rjx9ip1g012p
BEAT
20 May 24
% for HeartBeam AI+VCG vs. 69.4% for EP panel).
Demonstrated a statistically significant 6% improvement
dki2hnwx3e0jjov6melq lert
EOLS
20 May 24
dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary
9nnsfev0quoyuhxwznpcawlifn19lsj3sv7yfqiohbtyjkqccbt1kvp sk
BAER
20 May 24
) Bridger's exploration of, need for, or completion of any future financings, and (6) anticipated investments in additional aircraft, capital resources
fxrnjq7w5bwhzf8s26doe0kwioeqn8hqwzy8abl2
20 May 24
of patients with sustained persistent AF lasting 6 months or longer prior to enrollment. Patients in the Tailored cohort experienced a higher rate
bycryk836oa4rw3cmoabsd3fvg2fe1kt7x9twxeee8s444s78gg
20 May 24
factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended
0ve8voynmocarqivf18vi9pxwa
AIXI
20 May 24
as its current reports on Form 6-K and other filings, all of which are available for review
v8btfgeixrfmjdvnp
MESA
20 May 24
filings with the SEC, including the risk factors contained in its most recent Annual Report on Form 10-K and the Company's other subsequent filings
naftki4qz 721w23kk6scp3htw
CATX
20 May 24
Session: MTA06 – Molecular Targeting Probes 1Date and Time: Sunday, June 9, 2024, 6:30 p.m. EDT